Column Group III-A, LP

10% OwnerTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Feb 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2026Sell(S)2.2M$0.68$1.5M2.7M
Feb 11, 2026Sell(S)1.9M$0.68$1.3M2.3M
Feb 10, 2026Sell(S)161K$0.82$132K4.3M
Feb 10, 2026Sell(S)182K$0.82$149K4.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-049028) within minutes of acceptance. Every field above traces to the original document. Verify it directly: